Find uplifting stories about heroes, innovations, and solutions
14415 results for "depression research"
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
Researchers have identified two specific brain cell types that function differently in people with depression, marking a major step toward targeted treatments. The discovery proves depression is rooted in measurable biological changes, not just emotions.
A major clinical trial found that caffeine worked better than tiny doses of LSD for treating depression, challenging years of Silicon Valley hype. The research suggests microdosing's benefits may be mostly placebo effect.
Researchers at a Hyderabad institute created a groundbreaking model to study how chronic stress affects women's brains differently. The breakthrough could unlock better treatments for depression in females, who experience the condition at twice the rate of men.
Researchers discovered exactly how ketamine helps depression and created a safer alternative using three low-dose drugs. The breakthrough could help millions who don't respond to current treatments.
A groundbreaking clinical trial shows one dose of the psychedelic DMT significantly reduced depression symptoms for up to six months. For millions who haven't found relief from traditional treatments, this research opens a promising new door.
UC Davis researchers have developed new compounds that could treat depression and PTSD with the healing power of psychedelics but without hallucinations. The breakthrough discovery uses simple amino acids and UV light to create an entirely new class of mental health treatments.
President Trump signed an order in April to speed up research into psychedelic treatments for mental health conditions, offering new hope for veterans and others struggling with depression and PTSD. Scientists are cautiously optimistic about the medical potential while carefully studying safety.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
New research shows one ketamine infusion can reduce severe depression symptoms within hours, not weeks. For people with treatment-resistant depression, this rapid-acting treatment offers hope when traditional antidepressants fail.
Scientists discovered why exercise and enriched environments reduce depression risk. A brain protein called Fgf2 keeps the brain's protective barrier strong during stress, potentially offering the first biomarker for depression.
Scientists have tested a surprising new approach to treating depression by targeting inflammation instead of brain chemicals alone. In a small UK trial, an arthritis drug helped 54% of patients with hard-to-treat depression achieve remission.
Thousands of people told their depression was "treatment-resistant" found relief when doctors treated their cardiovascular system instead of their brain. The discovery could transform care for the 30% of depression patients who don't respond to traditional medications.
Leading autism researchers and advocates formed a new independent committee to guide autism research priorities and counter recent federal changes. The group aims to unite the autism community and protect evidence-based research as funding reaches $568 million annually.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
A scientist who revolutionized protein research is now tackling science's reproducibility crisis with AI. His new approach could help researchers separate reliable studies from questionable ones, speeding up cures for diseases like Alzheimer's.
Scientists now have access to an AI tool that filters through 150 years of research data to deliver trustworthy answers in seconds. CAS Newton helps researchers move from question to verified answer without drowning in information overload.
When US funding cuts threatened to collapse decades of life-saving health research in South Africa, the country fought back with a $32 million rescue package. Now 59 critical HIV and tuberculosis research projects are moving forward.
Showing 20 of 14415